φYeO3-12 phage tail fiber Gp17 as a promising high specific tool for recognition of Yersinia enterocolitica pathogenic serotype O:3.

Diagnostic ELISA Phage Phage adhesins Tail fiber protein Yersinia enterocolitica Yersiniosis

Journal

AMB Express
ISSN: 2191-0855
Titre abrégé: AMB Express
Pays: Germany
ID NLM: 101561785

Informations de publication

Date de publication:
06 Jan 2022
Historique:
received: 20 10 2021
accepted: 19 12 2021
entrez: 6 1 2022
pubmed: 7 1 2022
medline: 7 1 2022
Statut: epublish

Résumé

Yersiniosis is an infectious zoonotic disease caused by two enteropathogenic species of Gram-negative genus Yersinia: Yersinia enterocolitica and Yersinia pseudotuberculosis. Pigs and other wild and domestic animals are reservoirs for these bacteria. Infection is usually spread to humans by ingestion of contaminated food. Yersiniosis is considered a rare disease, but recent studies indicate that it is overlooked in the diagnostic process therefore the infections with this bacterium are not often identified. Reliable diagnosis of Yersiniosis by culturing is difficult due to the slow growth of the bacteria easily overgrown by other more rapidly growing microbes unless selec-tive growth media is used. Phage adhesins recognizing bacteria in a specific manner can be an excellent diagnostic tool, es-pecially in the diagnosis of pathogens difficult for culturing. In this study, it was shown that Gp17, the tail fiber protein (TFP) of phage φYeO3-12, specifically recognizes only the pathogenic Yersinia enterocolitica serotype O:3 (YeO:3) bacteria. The ELISA test used in this work confirmed the specific interaction of this protein with YeO:3 and demonstrated a promising tool for developing the pathogen recognition method based on phage adhesins.

Identifiants

pubmed: 34989907
doi: 10.1186/s13568-021-01341-2
pii: 10.1186/s13568-021-01341-2
pmc: PMC8739404
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1

Subventions

Organisme : Narodowym Centrum Nauki
ID : National Science Center
Organisme : Narodowym Centrum Nauki
ID : Poland (Grant Numbers UMO-2017/26/E/NZ1/00249).

Informations de copyright

© 2022. The Author(s).

Références

Infect Immun. 2001 Mar;69(3):1389-93
pubmed: 11179303
J Biol Chem. 2010 Sep 3;285(36):28333-42
pubmed: 20595390
Methods Mol Biol. 2009;498:105-15
pubmed: 18988021
J Clin Microbiol. 2015 Jan;53(1):146-59
pubmed: 25355759
Biomed Res Int. 2020 May 23;2020:1240626
pubmed: 32566652
J Appl Bacteriol. 1984 Jun;56(3):355-63
pubmed: 6146593
mSystems. 2019 Apr 23;4(2):
pubmed: 31020044
Enferm Infecc Microbiol Clin. 2012 Jan;30(1):24-32
pubmed: 22019131
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
Methods Mol Biol. 2011;681:281-93
pubmed: 20978971
J Histochem Cytochem. 2002 Jun;50(6):863-73
pubmed: 12019302
Molecules. 2020 Sep 24;25(19):
pubmed: 32987777
Viruses. 2016 Apr 22;8(4):111
pubmed: 27110815
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
BMC Microbiol. 2018 Aug 17;18(1):86
pubmed: 30119648
Mol Microbiol. 1999 Mar;31(5):1443-62
pubmed: 10200964
Front Cell Infect Microbiol. 2017 Sep 05;7:387
pubmed: 28929087
Innate Immun. 2016 Apr;22(3):205-17
pubmed: 26873504
Infect Immun. 1992 Mar;60(3):870-5
pubmed: 1311707
Virol J. 2014 Oct 28;11:188
pubmed: 25347934
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2301-2306
pubmed: 30238343
J Bacteriol. 2000 Sep;182(18):5114-20
pubmed: 10960095
Viruses. 2019 Nov 28;11(12):
pubmed: 31795231
BMC Genomics. 2011 Jul 06;12:348
pubmed: 21733159

Auteurs

Karolina Filik (K)

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 R. Weigl St, 53114, Wroclaw, Poland.

Bożena Szermer-Olearnik (B)

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 R. Weigl St, 53114, Wroclaw, Poland.

Joanna Niedziółka-Jönson (J)

Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44, 5201-224, Warsaw, Poland.

Ewa Roźniecka (E)

Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44, 5201-224, Warsaw, Poland.

Jarosław Ciekot (J)

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 R. Weigl St, 53114, Wroclaw, Poland.

Anna Pyra (A)

Faculty of Chemistry, University of Wroclaw, 14 F. Joliot-Curie St, 50383, Wroclaw, Poland.

Irwin Matyjaszczyk (I)

Department of Mycology and Genetics, Institute of Genetics and Microbiology, University of Wrocław, 51-148, Wroclaw, Poland.

Mikael Skurnik (M)

Department of Bacteriology and Immunology, Faculty of Medicine, Human Microbiome Research Program, University of Helsinki, Helsinki, Finland.
Division of Clinical Microbiology, Helsinki University Hospital, HUSLAB, Helsinki, Finland.

Ewa Brzozowska (E)

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 R. Weigl St, 53114, Wroclaw, Poland. ewa.brzozowska@hirszfeld.pl.

Classifications MeSH